Position in TWST
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$105,197,474
+$77,412,721 QoQ
Shares Held
1,022,526
+74.9% QoQ
Ownership
1.63%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#19
of 334 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in TWST Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Driehaus Capital Management LLC holds $537,568,705 across 6 Diagnostics & Research names. TWST ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
1,533,985 | $230,143,769 | |
| 2 | TWST |
Twist Bioscience Corp
This page
|
1,022,526 | $105,197,474 | |
| 3 | NTRA |
Natera, Inc.
|
383,872 | $104,202,054 | |
| 4 | VCYT |
Veracyte, Inc.
|
1,045,826 | $61,421,360 | |
| 5 | NEO |
Neogenomics Inc
|
2,508,845 | $36,604,048 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
631,926 | $0 |
All Filings in TWST
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105,197,474 | 1,022,526 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $27,784,753 | 584,696 | Shares | Sole | 2026-05-15 | |
| 2024-03-31 | $8,178,920 | 238,383 | Shares | Sole | 2024-05-15 | |
| 2021-03-31 | $14,749,496 | 119,082 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $44,165,558 | 312,588 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $34,272,801 | 451,136 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $24,678,488 | 544,779 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $13,702,775 | 448,096 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||